Breakthrough in lung cancer diagnosis in Zurich: robot helps detect tumors as small as 11 mm.
Lung cancer is one of the most dangerous forms of cancer because it often presents no symptoms in the early stages. That is why timely diagnosis plays a crucial role: the earlier a tumor is detected, the greater the chances of a full recovery.
Recently, a major breakthrough in modern medicine was achieved at a clinic in Zurich: researchers demonstrated for the first time worldwide that robotic bronchoscopy significantly outperforms traditional methods, enabling the detection of even the smallest and most hard-to-reach tumors.
Robotic bronchoscopy: diagnostic accuracy three times higher
As part of a clinical study, specialists examined **78 patients** and analyzed **127 small lesions** in the peripheral regions of the lungs—precisely where standard methods often prove ineffective.
The results were impressive:
- with traditional bronchoscopy, a biopsy was successfully performed in only **23% of cases**
- the CT-guided robotic system achieved success in over **84% of cases**
- even when the standard method failed, the robotic system enabled tissue collection for analysis in nearly **93% of cases**
This means one thing: **the likelihood of an accurate diagnosis increased nearly threefold**.
Why is this important? Because every millimeter can save a life.
Tumors detected using robotic technology averaged just 11 mm in size.
This is critically important in oncology:
the smaller the tumor, the higher the chance of a cure.
Specialists emphasize that an increase in tumor size of just one centimeter can worsen the prognosis by approximately 10%.
In other words, early detection can literally be the deciding factor between complex treatment and the chance of a full recovery.
Lung cancer can now be detected at an early stage.
One of the key advantages of robotic bronchoscopy is the ability to diagnose lung cancer at Stage I, when the disease is still amenable to effective treatment.
Previously, many cases were detected only at Stage IV, when treatment becomes significantly more complex and the prognosis less favorable.
With the introduction of this technology at the clinic in Zurich, the situation has changed dramatically: the majority of newly diagnosed cases now fall into the early, potentially curable stages.
Access to any part of the lungs — even the most hard-to-reach areas.
The robotic system enables the physician to navigate with high precision to any part of the lungs, including peripheral zones that were previously virtually inaccessible to standard bronchoscopes.
Since 2024, approximately 600 biopsies have been performed at the Zurich clinic using this technology.
The Future of Medicine: Diagnosis and Treatment in a Single Procedure
The next stage of development is combining diagnosis and treatment into a single procedure.
Researchers are exploring the possibility of enabling a physician to:
- take a tumor biopsy
- and immediately destroy it using radio waves or microwaves (ablation)
This could mean that the patient would not have to undergo multiple stages of treatment or wait a long time for a diagnosis to be confirmed.
Hope for patients: when technology truly saves lives
For many patients, a diagnosis of lung cancer feels like a death sentence. Yet modern technology proves otherwise: medicine is advancing so rapidly today that even small tumors can be detected early—before symptoms even appear.
And that is precisely what provides the most important things: time, a chance, and hope.
If you need a diagnosis or a second opinion in Switzerland
Modern diagnostic capabilities in Zurich enable the detection of lung tumors at early stages, precise disease staging, and the selection of the most effective treatment strategy.
If you wish to undergo an examination in Switzerland or receive professional medical support, we are ready to assist you at every stage—from organizing diagnostics to treatment and rehabilitation.